Sign in

Dr Chiara Herzog

@chiaraherzog.bsky.social
180 followers 220 following 8 posts

group leader @ cambridge stem cell institute www.herzog-lab.com

PostsRepliesMedia
Reposted by Dr Chiara Herzog
School of Biological Sciences @cambridgebiosci.bsky.social · 03/09/2026
Meet Chiara Herzog, new Theme Lead in Reproduction, Development and Lifelong Health. Chiara studies how switching genes on and off affects the life course of cells, with a primary focus on ageing. Learn more about #ResearchThemes: bio.cam.ac.uk @chiaraherzog.bsky.social @scicambridge.bsky.social
Teal graphic with white Reproduction, Development and Lifelong Health logo (three people behind health cross). Headshot of Theme Lead Chiara Herzog in a white circle. White text in quotation mark reads: 'Research across the School spans an amazing breadth - exactly what’s needed to tackle a complex challenge like the biology of ageing. As Theme Lead, I'm looking forward to connecting people across disciplines, from fundamental biology to translational research, and creating an environment where new or even unexpected collaborations flourish.'
031
Reposted by Dr Chiara Herzog
Fusion Conferences @fusionconf.bsky.social · 17/08/2026
Excited to welcome new names to our speaker line up! Our speakers will share cutting edge work on several mechanisms of aging, plus, the promise & challenges of translating them into interventions to improve human health during aging. Keep up to date➡️ bit.ly/3SZZGpb #FusionAgingResearch
131
Reposted by Dr Chiara Herzog
XPRIZE @xprize.org · 07/07/2026
How do you measure “immune age?” A new @natmed.nature.com paper, co-authored by #XPRIZEHealthspan’s @jamienjustice.bsky.social and developed with the Biomarkers of Aging Consortium, proposes the first standardized framework for clinical trials. Read more: www.nature.com/articles/s41...
012
Reposted by Dr Chiara Herzog
Advanced Research + Invention Agency (ARIA) @aria-research.bsky.social · 25/06/2026
Meet the 11 teams we’re funding in Sustained Viral Resilience 💥 Backed by £57m, they’ll unlock a new class of medicines that provide durable, broad-spectrum protection against respiratory viruses by engineering the innate immune system. Read more: link.aria.org.uk/svr-creators-bs
084
Dr Chiara Herzog @chiaraherzog.bsky.social · 30/07/2025
Final call for Abstracts for our 2025 Biomarkers of Aging Conference at Harvard Medical School! We'd love to hear from you so please consider submitting your work - we'll have speaking slots, flash talks, and poster prizes :) 👉 submit your work by Jul 31: www.agingconsortium.org/2025-poster
agingconsortium.org
Submit a Poster - Biomarkers of Aging Conference 2025 — Biomarkers of Aging Consortium
Present a poster at our 2025 Biomarkers of Aging Conference.
110
Reposted by Dr Chiara Herzog
Decoding Longevity @decodinglongevity.bsky.social · 17/07/2025
We can clock your biological age with just a few drops of blood. So why isn’t your doctor using it? Because translating science into clinical tools is messy. Really messy. New @DecodingLongev episode with @chiaraherzog.bsky.social 🎧 Ep9: The Biomarkers of Aging Bottleneck
101
Reposted by Dr Chiara Herzog
Front Line Genomics @flgenomics.bsky.social · 29/05/2025
The fantastic lineup for our latest webinar series, Unlocking the Epigenome: Precision Tools for Complex Diseases, includes: @chiaraherzog.bsky.social, @a-radzisheuskaya.bsky.social, @sankarinagarajan.bsky.social, @sebpreissl.bsky.social, @scherermich.bsky.social, and more! Check them out below!
023
Reposted by Dr Chiara Herzog
Climate, Ecology, War & More: Dr. Glen Barry BigEarthData.ai @bigearthdata.ai · 02/04/2025
Systems epigenetic approach towards non-invasive breast cancer detection ->Nature | More info from EcoSearch
nature.com
Systems epigenetic approach towards non-invasive breast cancer detection
We initially performed an epigenome-wide analysis of DNAme changes associated with breast cancer in the three surrogate tissues (buccal, cervical, and blood; Fig. 1a), looking at both individually differentially methylated positions (DMPs) and differentially methylated regions (DMRs), accounting for age...
011
Dr Chiara Herzog @chiaraherzog.bsky.social · 12/03/2025
joining #epigenomics25 for the next days at wellcome’s genome campus. fantastic talks so far and amazing to get to nerd out about my favourite topic ✨ @jordanatbell.bsky.social
051
Dr Chiara Herzog @chiaraherzog.bsky.social · 11/02/2025
Hugely honoured to receive the 𝗣𝗿𝗼𝗳𝗲𝘀𝘀𝗼𝗿 𝗔𝗻𝘁𝗵𝗼𝗻𝘆 𝗠𝗲𝗹𝗹𝗼𝘄𝘀 𝗠𝗲𝗱𝗮𝗹 🏅 Awarded during the 2025 @kingslsm.bsky.social winter graduation ceremony, this prestigious medal not only recognises my previous work but also supports my independent research through a fellowship to establish my research programme.
The Professor Anthony Mellows medal being awarded to me by Prof. Ajay Shah and Lord Simon Stevens.The Professor Anthony Mellows medal award during the 2025 King's Faculty of Life Science and Medicine winter graduations on stage.
120
Reposted by Dr Chiara Herzog
Oded Rechavi @odedrechavi.bsky.social · 26/01/2025
That's a beautiful and important paper
14611
Reposted by Dr Chiara Herzog
George J. Murphy @drgjmurphy.bsky.social · 30/11/2024
Many thanks to @natureportfolio.bsky.social for featuring our work creating and profiling stem cells from centenarians! www.nature.com/articles/d41...
nature.com
What’s the secret to living to 100? Centenarian stem cells could offer clues
A bank of cells from people more than 100 years old gives scientists a new resource for studying longevity.
031
Dr Chiara Herzog @chiaraherzog.bsky.social · 27/10/2023
🔬 new findings on breast cancer risk prediction: our study in npj Precision Oncology reveals the power of epigenetics in understanding risk, focusing genetic X nonheritable factors captured on the epigenome in the "right" surrogate sample 🧬 #BreastCancer #Epigenetics #CancerResearch #DNAmethylation
doi.org
DNA methylation at quantitative trait loci (mQTLs) varies with cell type and nonheritable factors an...
npj Precision Oncology - DNA methylation at quantitative trait loci (mQTLs) varies with cell type and nonheritable factors and may improve breast cancer risk assessment
050